Djouad F - Search Results

1

Mesenchymal Stem Cells Improve Rheumatoid Arthritis Progression by Controlling Memory T Cell Response.

Luque-Campos N, Contreras-López RA, Jose Paredes-Martínez M, Torres MJ, Bahraoui S, Wei M, Espinoza F, Djouad F, Elizondo-Vega RJ, Luz-Crawford P. Luque-Campos N, et al. Among authors: djouad f. Front Immunol. 2019 Apr 16;10:798. doi: 10.3389/fimmu.2019.00798. eCollection 2019. Front Immunol. 2019. PMID: 31040848 Free PMC article. Review.

2

Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis.

Djouad F, Fritz V, Apparailly F, Louis-Plence P, Bony C, Sany J, Jorgensen C, Noël D. Djouad F, et al. Arthritis Rheum. 2005 May;52(5):1595-603. doi: 10.1002/art.21012. Arthritis Rheum. 2005. PMID: 15880818 Free article.

3

Engineered mesenchymal stem cells for cartilage repair.

Djouad F, Mrugala D, Noël D, Jorgensen C. Djouad F, et al. Regen Med. 2006 Jul;1(4):529-37. doi: 10.2217/17460751.1.4.529. Regen Med. 2006. PMID: 17465847 Review.

4

Multipotent mesenchymal stromal cells and immune tolerance.

Noël D, Djouad F, Bouffi C, Mrugala D, Jorgensen C. Noël D, et al. Among authors: djouad f. Leuk Lymphoma. 2007 Jul;48(7):1283-9. doi: 10.1080/10428190701361869. Leuk Lymphoma. 2007. PMID: 17613755 Review.

5

Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit?

Bouffi C, Djouad F, Mathieu M, Noël D, Jorgensen C. Bouffi C, et al. Among authors: djouad f. Rheumatology (Oxford). 2009 Oct;48(10):1185-9. doi: 10.1093/rheumatology/kep162. Epub 2009 Jun 26. Rheumatology (Oxford). 2009. PMID: 19561159 Review.

6

Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases.

Djouad F, Bouffi C, Ghannam S, Noël D, Jorgensen C. Djouad F, et al. Nat Rev Rheumatol. 2009 Jul;5(7):392-9. doi: 10.1038/nrrheum.2009.104. Nat Rev Rheumatol. 2009. PMID: 19568253 Review.

7

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications.

Ghannam S, Bouffi C, Djouad F, Jorgensen C, Noël D. Ghannam S, et al. Among authors: djouad f. Stem Cell Res Ther. 2010 Mar 15;1(1):2. doi: 10.1186/scrt2. Stem Cell Res Ther. 2010. PMID: 20504283 Free PMC article.

8

Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway.

Luz-Crawford P, Noël D, Fernandez X, Khoury M, Figueroa F, Carrión F, Jorgensen C, Djouad F. Luz-Crawford P, et al. Among authors: djouad f. PLoS One. 2012;7(9):e45272. doi: 10.1371/journal.pone.0045272. Epub 2012 Sep 17. PLoS One. 2012. PMID: 23028899 Free PMC article.

9

Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.

Luz-Crawford P, Kurte M, Bravo-Alegría J, Contreras R, Nova-Lamperti E, Tejedor G, Noël D, Jorgensen C, Figueroa F, Djouad F, Carrión F. Luz-Crawford P, et al. Among authors: djouad f. Stem Cell Res Ther. 2013 Jun 4;4(3):65. doi: 10.1186/scrt216. Stem Cell Res Ther. 2013. PMID: 23734780 Free PMC article.

10

Glucocorticoid-induced leucine zipper governs the therapeutic potential of mesenchymal stem cells by inducing a switch from pathogenic to regulatory Th17 cells in a mouse model of collagen-induced arthritis.

Luz-Crawford P, Tejedor G, Mausset-Bonnefont AL, Beaulieu E, Morand EF, Jorgensen C, Noël D, Djouad F. Luz-Crawford P, et al. Among authors: djouad f. Arthritis Rheumatol. 2015 Jun;67(6):1514-24. doi: 10.1002/art.39069. Arthritis Rheumatol. 2015. PMID: 25708718

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page